PHAXIAM Therapeutics Dirección
Dirección controles de criterios 1/4
Actualmente no disponemos de información suficiente sobre el CEO.
Información clave
Thibaut Fayet
Chief Executive Officer (CEO)
n/a
Compensación total
Porcentaje del salario del CEO | n/a |
Permanencia del CEO | less than a year |
Participación del CEO | n/a |
Permanencia media de la dirección | less than a year |
Promedio de permanencia en la Junta Directiva | 10.8yrs |
Actualizaciones recientes de la dirección
Recent updates
ERYTECH receives non-compliance letter from Nasdaq
Oct 13Erytech Pharma reports 1H results
Sep 12Erytech drops plans to pursue FDA approval for leukemia therapy
Aug 24Our First Look At ERYTECH Pharma
Nov 16ERYTECH Pharma S.A. 2021 Q1 - Results - Earnings Call Presentation
May 06ERYTECH starts patient enrollment in pancreatic cancer study
Jan 14ERYTECH secures €10M in non-dilutive financing
Nov 02ERYTECH: Trials In Pancreatic Cancer
Oct 23CEO
Thibaut Fayet (55 yo)
less than a year
Permanencia
Mr. Thibaut du Fayet serves as Chief Executive Officer at PHAXIAM Therapeutics S.A. since June 23, 2023. He served as Chief Operating Officer and served as Member of the Executive Board at Pherecydes Pharm...
Equipo directivo
Nombre | Posición | Permanencia | Compensación | Propiedad |
---|---|---|---|---|
Deputy CEO | 8.5yrs | €379.72k | 0.010% € 1.9k | |
Deputy CEO | 4.2yrs | €247.91k | 0.0063% € 1.2k | |
Chief Executive Officer | less than a year | sin datos | sin datos | |
Chief Technology Officer | less than a year | sin datos | sin datos | |
Chief Scientific Officer | 1.2yrs | sin datos | sin datos | |
Director Investor Relations | no data | sin datos | sin datos | |
Vice President of Human Resources | 8.1yrs | sin datos | 0.0014% € 268.6 | |
Chief Business Officer | less than a year | sin datos | 0.00066% € 124.8 | |
Chief Medical Officer | less than a year | sin datos | sin datos | |
Chief Regulatory Officer | less than a year | sin datos | sin datos | |
Consultant & Member of Scientific Board | no data | sin datos | sin datos | |
Consultant & Member of Scientific Board | no data | sin datos | sin datos |
0.8yrs
Permanencia media
52yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de PHXM no se considera experimentado ( 0.8 años antigüedad media), lo que sugiere un nuevo equipo.
Miembros de la Junta
Nombre | Posición | Permanencia | Compensación | Propiedad |
---|---|---|---|---|
Consultant & Member of Scientific Board | 14.2yrs | sin datos | sin datos | |
Consultant & Member of Scientific Board | 14.4yrs | sin datos | sin datos | |
Consultant & Member of Scientific Board | 12.2yrs | sin datos | sin datos | |
Consultant & Member of Scientific Board | 12.2yrs | sin datos | sin datos | |
Consultant & Member of Scientific Board | 12.2yrs | sin datos | sin datos | |
Independent Director | 10.8yrs | €66.00k | 0.017% € 3.2k | |
Vice Chairman | 10.8yrs | €572.43k | 0.0080% € 1.5k | |
Independent Director | 9.8yrs | €51.00k | 0.000020% € 3.8 | |
Independent Director | 9.5yrs | €51.00k | 0.000020% € 3.8 | |
Chairman of the Board | less than a year | sin datos | sin datos | |
Representative Director | 1.2yrs | sin datos | sin datos | |
Independent Director | less than a year | sin datos | sin datos |
10.8yrs
Permanencia media
62yo
Promedio de edad
Junta con experiencia: Los miembros de la junta directiva de PHXM son experimentados ( 10.8 años antigüedad media).